VisionCare Ophthalmic Technologies Inc., a private company based in Saratoga, California, have announced the US expansion of availability of their implantable miniature telescope. The recently launched ophthalmic medical device, approved for the monocular treatment of end-stage macular degeneration, will now be available in over 30 locations including Los Angeles, Chicago, Honolulu, Atlanta, Denver, New York, Boston, Tucson, Washington, D.C., Salt Lake City, Seattle, St. Louis and Charlotte. The company has facilitated the expansion through the development of teams of multidisciplinary healthcare specialists trained in patient evaluation, surgical treatment and visual rehabilitation to screen patients for eligibility. A website, www.CentraSight.com, additionally outlines the treatment programme for the miniature telescope in addition to other relevant information.